“Industry Leaders Are Right to Question Hemps Chemically Converted Cannabinoids of Unknown Composition. MMJ Says the Same Questions Must Be Asked of State-Licensed Marijuana Products Granted Federal Schedule III Treatment Without FDA Review,” stated Duane Boise CEO MMJ International Holdings.
Post Views: 17



